- Home
- SNTI vs JZXN Comparison
SNTI vs JZXN Comparison
Compare SNTI & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- JZXN
- Stock Information
- Founded
- SNTI 2016
- JZXN 2017
- Country
- SNTI United States
- JZXN China
- Employees
- SNTI N/A
- JZXN N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- SNTI Health Care
- JZXN Consumer Discretionary
- Exchange
- SNTI Nasdaq
- JZXN Nasdaq
- Market Cap
- SNTI 18.2M
- JZXN 10.7M
- IPO Year
- SNTI N/A
- JZXN 2021
- Fundamental
- Price
- SNTI $3.97
- JZXN $1.59
- Analyst Decision
- SNTI Strong Buy
- JZXN
- Analyst Count
- SNTI 1
- JZXN 0
- Target Price
- SNTI $12.00
- JZXN N/A
- AVG Volume (30 Days)
- SNTI 7.2M
- JZXN 773.4K
- Earning Date
- SNTI 11-14-2024
- JZXN 01-03-2025
- Dividend Yield
- SNTI N/A
- JZXN N/A
- EPS Growth
- SNTI N/A
- JZXN N/A
- EPS
- SNTI N/A
- JZXN N/A
- Revenue
- SNTI N/A
- JZXN $7,597,423.00
- Revenue This Year
- SNTI $254.47
- JZXN N/A
- Revenue Next Year
- SNTI $169.66
- JZXN N/A
- P/E Ratio
- SNTI N/A
- JZXN N/A
- Revenue Growth
- SNTI N/A
- JZXN 81.94
- 52 Week Low
- SNTI $1.52
- JZXN $1.00
- 52 Week High
- SNTI $16.94
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- SNTI 47.37
- JZXN 53.88
- Support Level
- SNTI $3.60
- JZXN $1.31
- Resistance Level
- SNTI $5.96
- JZXN $1.65
- Average True Range (ATR)
- SNTI 1.02
- JZXN 0.38
- MACD
- SNTI -0.29
- JZXN 0.01
- Stochastic Oscillator
- SNTI 5.74
- JZXN 46.34
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.